Cytodyn Financials

CYDY Stock  USD 0.14  0.01  7.69%   
Based on the analysis of Cytodyn's profitability, liquidity, and operating efficiency, Cytodyn is not in a good financial situation at the moment. It has a very high risk of going through financial straits in July.
With this module, you can analyze Cytodyn financials for your investing period. You should be able to track the changes in Cytodyn individual financial statements over time to develop the understanding of its risk, liquidity, profitability, or other critical and vital indicators.
Understanding current and past Cytodyn Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Cytodyn's financial statements are interrelated, with each one affecting the others. For example, an increase in Cytodyn's assets may result in an increase in income on the income statement.
The data published in Cytodyn's official financial statements typically reflect Cytodyn's business processes, product offerings, services, and other fundamental events. However, there are additional fundamental indicators that are easier to understand and visualize along the underlying realities that are driving Cytodyn's quantitative information. For example, before you start analyzing numbers published by Cytodyn accountants, it's essential to understand Cytodyn's liquidity, profitability, and earnings quality within the context of the Biotechnology space in which it operates.
Please note, the imprecision that can be found in Cytodyn's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Cytodyn. Check Cytodyn's Beneish M Score to see the likelihood of Cytodyn's management manipulating its earnings.

Cytodyn Stock Summary

Cytodyn competes with Bank Rakyat, PT Bank, Telkom Indonesia, PT Astra, and Astra International. CytoDyn Inc. operates as a clinical-stage biotechnology company. CytoDyn Inc. was incorporated in 2002 and is based in Vancouver, Washington. Cytodyn operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 23 people.
InstrumentUSA OTC Stock View All
ExchangeOTCQB Exchange
Business Address1111 Main Street,
IndustryHealth Care
BenchmarkDow Jones Industrial
Phone360 980 8524
CurrencyUSD - US Dollar

Cytodyn Key Financial Ratios

Cytodyn's financial ratios allow both analysts and investors to convert raw data from Cytodyn's financial statements into concise, actionable information that can be used to evaluate the performance of Cytodyn over time and compare it to other companies across industries.

Cytodyn Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Cytodyn's current stock value. Our valuation model uses many indicators to compare Cytodyn value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Cytodyn competition to find correlations between indicators driving Cytodyn's intrinsic value. More Info.
Cytodyn is number one stock in return on asset category among its peers. It also is the top company in current valuation category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Cytodyn by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Cytodyn's OTC Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.

Cytodyn Systematic Risk

Cytodyn's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Cytodyn volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twenty-four with a total number of output elements of thirty-seven. The Beta measures systematic risk based on how returns on Cytodyn correlated with the market. If Beta is less than 0 Cytodyn generally moves in the opposite direction as compared to the market. If Cytodyn Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Cytodyn is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Cytodyn is generally in the same direction as the market. If Beta > 1 Cytodyn moves generally in the same direction as, but more than the movement of the benchmark.

Cytodyn June 24, 2024 Opportunity Range

Along with financial statement analysis, the daily predictive indicators of Cytodyn help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Cytodyn. We use our internally-developed statistical techniques to arrive at the intrinsic value of Cytodyn based on widely used predictive technical indicators. In general, we focus on analyzing Cytodyn OTC Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Cytodyn's daily price indicators and compare them against related drivers.

Additional Tools for Cytodyn OTC Stock Analysis

When running Cytodyn's price analysis, check to measure Cytodyn's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cytodyn is operating at the current time. Most of Cytodyn's value examination focuses on studying past and present price action to predict the probability of Cytodyn's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cytodyn's price. Additionally, you may evaluate how the addition of Cytodyn to your portfolios can decrease your overall portfolio volatility.